Family Legacy Inc’s Thermo Fisher Scientific TMO Stock Holding History

Family Legacy Inc’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.88M	Buy	2,779 +13	+0.5%	+$7.72K	0.52%	68
2026 Q2	$1.39M	Sell	2,766 -8	-0.3%	-$3.84K	0.37%	75
2026 Q1	$1.36M	Buy	2,774 +27	+1%	+$14.7K	0.41%	75
2025 Q4	$1.59M	Buy	2,747 +16	+0.6%	+$9.05K	0.48%	70
2025 Q3	$1.32M	Buy	2,731 +4	+0.1%	+$1.86K	0.41%	74
2025 Q2	$1.11M	Buy	2,727 +37	+1%	+$15.5K	0.36%	82
2025 Q1	$1.34M	Buy	2,690 +26	+1%	+$14.1K	0.46%	72
2024 Q4	$1.45M	Buy	2,664 +147	+6%	+$80.8K	0.49%	69
2024 Q3	$1.56M	Buy	2,517 +107	+4%	+$63.3K	0.52%	68
2024 Q2	$1.33M	Buy	2,410 +42	+2%	+$24.1K	0.48%	68
2024 Q1	$1.38M	Buy	2,368 +67	+3%	+$37.6K	0.49%	71
2023 Q4	$1.22M	Buy	2,301 +106	+5%	+$51.3K	0.47%	72
2023 Q3	$1.11M	Buy	2,195 +67	+3%	+$35.7K	0.46%	70
2023 Q2	$1.11M	Buy	2,128 +26	+1%	+$14K	0.45%	73
2023 Q1	$1.21M	Buy	2,102 +170	+9%	+$95.8K	0.52%	70
2022 Q4	$1.11M	Buy	+1,932	New	+$1.02M	0.49%	70

Other funds holding TMO

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

GIA

Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.91B AUM 26.66% 1-Year Est. Return

CIPU

Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Family Legacy Inc's TMO Position: Q3 2026 in Review

Family Legacy Inc increased its Thermo Fisher Scientific (TMO) stake by 0.47% in Q3 2026, buying an estimated $7.72K and bringing the position to 2,779 shares worth $1.88M. The position accounts for 0.52% of the portfolio, ranked #68.

Family Legacy Inc first reported a position in TMO in Q4 2022 and has held it in 16 quarters since. 366 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Family Legacy Inc held 2,779 shares of Thermo Fisher Scientific worth $1.88M as of Q3 2026.
Family Legacy Inc bought 13 Thermo Fisher Scientific shares in Q3 2026, an estimated $7.72K.
Thermo Fisher Scientific made up 0.52% of Family Legacy Inc's portfolio in Q3 2026, its #68 holding.
Family Legacy Inc first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 16 quarters since.
366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Family Legacy Inc's 13F filing for Q3 2026, filed 13 Oct 2026.